Egfr Tki For Advanced Nsclc Market Size And Share

Report Code : TIPRE00018975
Category : Life Sciences

No. of Pages : 150

Buy Now

Análisis de la cuota de mercado y oportunidades de EGFR-TKI para el CPNM avanzado (2025-2031)

Buy Now

EGFR-TKI for Advanced NSCLC Market Report Analysis

EGFR-TKI for Advanced NSCLC Market

CAGR (2023 - 2031)
XX%
Market Size 2023
US$ XX million
Market Size 2031
US$ XX Million

Report Coverage

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis

Industry landscape and competition analysis & recent developments
Detailed company profiles

Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

Beta pharma Ltd
Actiza pharmaceuticals
AstraZeneca
Sun Pharmaceuticals
Roche
Teva Pharmaceutical Industries
Armas Pharmaceuticals, Inc
Boehringer Ingelheim
Rewine Pharmaceutical

Regional Overview

América del Norte
Europa
Asia-Pacífico
América del Sur y Central
Medio Oriente y África

Market Segmentation

By Tipo

Gefitinib
Erlotinib
Afatinib
Icotinib

By Tipo de terapia

monoterapia
terapia combinada

By Usuario final

Hospitales
Centros Oncológicos
Otros

By Geografía

América del Norte
Europa
Asia-Pacífico
América del Sur y Central